Validate projections
Validate revenue projections and stress-test sales forecasts.
PAN India: evaluating market position, customer concentration and the multi-product potential of a manufacturing asset.
Due diligence must look outward as well as inward. A facility may meet high technical standards, yet its commercial value is at risk if it depends on a single distributor, faces product obsolescence or cannot add higher-value product lines.
Suchigo Consulting provides commercial due diligence for pharma and medical device businesses. We support acquirers and investors from India and overseas evaluating businesses across India, combining market research with a manufacturer’s understanding of products and plants. This connects what the facility can make with where those products can be sold.
Assessing domestic demand alongside opportunities across the USA, Europe, South America, Africa, South East Asia, the GCC and CIS countries.
| Area | What we review | What it tells you |
|---|---|---|
| Market research and competitor mapping | Key competitors, their capacities and product ranges, and sales channels including private, institutional and government tenders. | Who the company competes with and how strong its position is. |
| Domestic and international market consumption | Demand and growth trends in India and export markets such as the USA, Europe, South America, Africa, South East Asia, the GCC and CIS countries. | How large the opportunity is and where demand is growing. |
| Strategic market positioning | Product range, pricing resilience, distributor network, customer concentration and brand strength. | Whether the business can hold or grow its market share. |
| Future products using the same facility | Plant layout, utilities, cleanrooms, equipment and licence scope available for new or adjacent products. | How the facility can create additional value without major new capital investment. |
An acquisition is a bet on future revenue. Market research and competitor mapping test whether the growth in a business plan is realistic. Our assessment helps you:
Validate revenue projections and stress-test sales forecasts.
Identify customer and distributor concentration risks.
Build a multi-product roadmap for the acquired manufacturing site.
We agree the products, markets and questions the assessment needs to answer.
We study demand, consumption trends and the competitive landscape in India and target export markets.
We visit the site, PAN India, to understand its capabilities and the products it could add.
Your management receives a clear report on market position, growth potential and future product opportunities. After the report, Suchigo can advise on next steps, working alongside your team as catalyst and advisor.
Led by Mr. Sunil Gokhale, with over 43 years of CEO-level experience, our senior experts have led new product development and manufacturing projects across pharmaceutical formulations, APIs and medical devices, with a wide network of industry specialists to draw on.
We understand both the market and the plant, so we can judge which growth opportunities a facility can realistically deliver. We work alongside your team as catalyst and advisor. All assessments are carried out under strict confidentiality.
PAN India pharma and medical device projects. Connected to India? Talk to us. Share your requirement, and we’ll help you understand the market potential of the business you are evaluating.